Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.87261095 |
2 | leukocyte aggregation (GO:0070486) | 5.52027632 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.48167696 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.48167696 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.18418176 |
6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.07462455 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.99300520 |
8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.92996407 |
9 | negative regulation of cell killing (GO:0031342) | 4.82737859 |
10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.82737859 |
11 | detection of other organism (GO:0098543) | 4.78530759 |
12 | detection of bacterium (GO:0016045) | 4.74326162 |
13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.53951073 |
14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.31055307 |
15 | negative T cell selection (GO:0043383) | 4.27528600 |
16 | negative thymic T cell selection (GO:0045060) | 4.25688173 |
17 | positive thymic T cell selection (GO:0045059) | 4.13373965 |
18 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.07512299 |
19 | neutrophil activation involved in immune response (GO:0002283) | 4.04027739 |
20 | T cell migration (GO:0072678) | 4.01928196 |
21 | immunoglobulin mediated immune response (GO:0016064) | 3.97571194 |
22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.90478052 |
23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.88631478 |
24 | modulation by symbiont of host defense response (GO:0052031) | 3.88631478 |
25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.88631478 |
26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.88631478 |
27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.88631478 |
28 | modulation by symbiont of host immune response (GO:0052553) | 3.88631478 |
29 | regulation of B cell differentiation (GO:0045577) | 3.86533262 |
30 | detection of external biotic stimulus (GO:0098581) | 3.85302097 |
31 | respiratory burst (GO:0045730) | 3.81723310 |
32 | response to interleukin-15 (GO:0070672) | 3.79548509 |
33 | interferon-gamma production (GO:0032609) | 3.71225190 |
34 | positive regulation of B cell differentiation (GO:0045579) | 3.69699245 |
35 | B cell receptor signaling pathway (GO:0050853) | 3.68470329 |
36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.68355940 |
37 | thymic T cell selection (GO:0045061) | 3.64897382 |
38 | regulation of mast cell degranulation (GO:0043304) | 3.62477907 |
39 | cellular response to interleukin-15 (GO:0071350) | 3.62286044 |
40 | cellular extravasation (GO:0045123) | 3.60886186 |
41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56720947 |
42 | negative regulation of phagocytosis (GO:0050765) | 3.55672294 |
43 | response to peptidoglycan (GO:0032494) | 3.54857078 |
44 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.54307650 |
45 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.52495160 |
46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.47809915 |
47 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.47769343 |
48 | T cell selection (GO:0045058) | 3.46545781 |
49 | neutrophil activation (GO:0042119) | 3.44895757 |
50 | tolerance induction (GO:0002507) | 3.43771071 |
51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.43042783 |
52 | regulation of tolerance induction (GO:0002643) | 3.42428596 |
53 | mast cell activation (GO:0045576) | 3.42357568 |
54 | positive T cell selection (GO:0043368) | 3.40960247 |
55 | detection of biotic stimulus (GO:0009595) | 3.36976740 |
56 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.36341696 |
57 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.35960929 |
58 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35322141 |
59 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.34525554 |
60 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.31669141 |
61 | leukocyte cell-cell adhesion (GO:0007159) | 3.31154692 |
62 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.29756678 |
63 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.29756678 |
64 | granulocyte activation (GO:0036230) | 3.29338481 |
65 | response to type I interferon (GO:0034340) | 3.29096740 |
66 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.27674519 |
67 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.27351502 |
68 | detection of molecule of bacterial origin (GO:0032490) | 3.26456901 |
69 | response to host (GO:0075136) | 3.26182898 |
70 | response to host defenses (GO:0052200) | 3.26182898 |
71 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26182898 |
72 | type I interferon signaling pathway (GO:0060337) | 3.25330971 |
73 | cellular response to type I interferon (GO:0071357) | 3.25330971 |
74 | B cell mediated immunity (GO:0019724) | 3.24987109 |
75 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24707240 |
76 | microglial cell activation (GO:0001774) | 3.24082617 |
77 | germinal center formation (GO:0002467) | 3.23659726 |
78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22953166 |
79 | positive regulation of antigen processing and presentation (GO:0002579) | 3.22109377 |
80 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.21314209 |
81 | myeloid dendritic cell activation (GO:0001773) | 3.18271331 |
82 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.16726679 |
83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14578510 |
84 | regulation of leukocyte degranulation (GO:0043300) | 3.13258064 |
85 | T cell costimulation (GO:0031295) | 3.13104931 |
86 | positive regulation of interferon-alpha production (GO:0032727) | 3.12498022 |
87 | defense response to protozoan (GO:0042832) | 3.11657366 |
88 | regulation of mast cell activation (GO:0033003) | 3.11247845 |
89 | negative regulation of interleukin-12 production (GO:0032695) | 3.11220859 |
90 | T cell receptor signaling pathway (GO:0050852) | 3.10657244 |
91 | sequestering of actin monomers (GO:0042989) | 3.10596546 |
92 | lymphocyte costimulation (GO:0031294) | 3.08445539 |
93 | cellular response to zinc ion (GO:0071294) | 3.07669019 |
94 | response to protozoan (GO:0001562) | 3.07198933 |
95 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.06791107 |
96 | neutrophil mediated immunity (GO:0002446) | 3.05073756 |
97 | macrophage activation (GO:0042116) | 3.04970530 |
98 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04239175 |
99 | myeloid cell activation involved in immune response (GO:0002275) | 3.03927089 |
100 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.03849540 |
101 | negative regulation of innate immune response (GO:0045824) | 3.02574867 |
102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.02154874 |
103 | NIK/NF-kappaB signaling (GO:0038061) | 3.02132464 |
104 | regulation of interferon-alpha production (GO:0032647) | 3.00482285 |
105 | myeloid dendritic cell differentiation (GO:0043011) | 3.00474778 |
106 | regulation of regulatory T cell differentiation (GO:0045589) | 2.99829247 |
107 | regulation of T cell tolerance induction (GO:0002664) | 2.95985321 |
108 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.95911291 |
109 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.95911291 |
110 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.95896269 |
111 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.95828757 |
112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94401833 |
113 | positive regulation of mast cell activation (GO:0033005) | 2.93401171 |
114 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.93167889 |
115 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.92930650 |
116 | positive regulation of isotype switching (GO:0045830) | 2.92458390 |
117 | T cell homeostasis (GO:0043029) | 2.92299266 |
118 | positive regulation of lamellipodium assembly (GO:0010592) | 2.92221132 |
119 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90676321 |
120 | regulation of response to interferon-gamma (GO:0060330) | 2.90435293 |
121 | response to muramyl dipeptide (GO:0032495) | 2.89702353 |
122 | actin nucleation (GO:0045010) | 2.89291088 |
123 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.86794639 |
124 | positive regulation of interleukin-2 production (GO:0032743) | 2.84889768 |
125 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.83715528 |
126 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.83214148 |
127 | mature B cell differentiation (GO:0002335) | 2.81578810 |
128 | macrophage activation involved in immune response (GO:0002281) | 2.79650969 |
129 | natural killer cell activation (GO:0030101) | 2.78739109 |
130 | leukocyte degranulation (GO:0043299) | 2.78618689 |
131 | regulation of antigen processing and presentation (GO:0002577) | 2.78281143 |
132 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75072959 |
133 | response to host immune response (GO:0052572) | 2.75072959 |
134 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.73775144 |
135 | ribosomal small subunit assembly (GO:0000028) | 2.73583852 |
136 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.72651826 |
137 | positive regulation of B cell mediated immunity (GO:0002714) | 2.72651826 |
138 | lymphocyte homeostasis (GO:0002260) | 2.72492810 |
139 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.71939210 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.73349905 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.36972152 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.17662748 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.08774299 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88512892 |
6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.61412200 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.60272829 |
8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.15488277 |
9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.03063698 |
10 | MYC_22102868_ChIP-Seq_BL_Human | 3.01925784 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.87491110 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.87285772 |
13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86089446 |
14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84695534 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.78072824 |
16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.73318084 |
17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.70487838 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70041746 |
19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68448140 |
20 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64390738 |
21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.63045930 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.55532175 |
23 | MAF_26560356_Chip-Seq_TH1_Human | 2.50300493 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.46561082 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.46509327 |
26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.45252755 |
27 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.42696813 |
28 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.22103132 |
29 | MYB_26560356_Chip-Seq_TH1_Human | 2.18287631 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.18286730 |
31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16837139 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14161925 |
33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13054817 |
34 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03209478 |
35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95021784 |
36 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93672100 |
37 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90370056 |
38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87813591 |
39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79300496 |
40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74981333 |
41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74535172 |
42 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71685143 |
43 | MAF_26560356_Chip-Seq_TH2_Human | 1.70599059 |
44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69133412 |
45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67967253 |
46 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63426810 |
47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55792844 |
48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54913784 |
49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50212426 |
50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50116007 |
51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45686444 |
52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45203564 |
53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43252954 |
54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42737502 |
55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41538339 |
56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37495730 |
57 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37375660 |
58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.34811676 |
59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34506632 |
60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30636650 |
61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28942075 |
62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28158687 |
63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26847654 |
64 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24825535 |
65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.23312216 |
66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22991542 |
67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21614170 |
68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21575794 |
69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21133012 |
70 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19161153 |
71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17963312 |
72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17539780 |
73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17163234 |
74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15838332 |
75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15773207 |
76 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.13896382 |
77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12622838 |
78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10899241 |
79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10855628 |
80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09459825 |
81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08924352 |
82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08820578 |
83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08774029 |
84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08694096 |
85 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08643816 |
86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07910888 |
87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06863305 |
88 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05958253 |
89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04133139 |
90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02877879 |
91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02362956 |
92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02033836 |
93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94350460 |
94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92291105 |
95 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91810198 |
96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91785691 |
97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91655444 |
98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91633958 |
99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88308458 |
100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87292581 |
101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86482238 |
102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84639066 |
103 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.83949970 |
104 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83794257 |
105 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81769822 |
106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81736841 |
107 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81554559 |
108 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.80445738 |
109 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80117832 |
110 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78447414 |
111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76419270 |
112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74311238 |
113 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73787387 |
114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73229420 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.17821967 |
2 | MP0005671_abnormal_response_to | 3.47636789 |
3 | MP0003436_decreased_susceptibility_to | 3.40811508 |
4 | MP0000685_abnormal_immune_system | 3.34058532 |
5 | MP0009785_altered_susceptibility_to | 3.21805681 |
6 | MP0003303_peritoneal_inflammation | 3.10390076 |
7 | MP0001800_abnormal_humoral_immune | 3.09242112 |
8 | MP0003763_abnormal_thymus_physiology | 3.02924677 |
9 | MP0001790_abnormal_immune_system | 3.01865316 |
10 | MP0005387_immune_system_phenotype | 3.01865316 |
11 | MP0005000_abnormal_immune_tolerance | 3.01227226 |
12 | MP0005025_abnormal_response_to | 2.83828110 |
13 | MP0002452_abnormal_antigen_presenting | 2.82392432 |
14 | MP0002723_abnormal_immune_serum | 2.75091670 |
15 | MP0002420_abnormal_adaptive_immunity | 2.73709310 |
16 | MP0002419_abnormal_innate_immunity | 2.72649998 |
17 | MP0001819_abnormal_immune_cell | 2.72200596 |
18 | MP0006082_CNS_inflammation | 2.58477209 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.58044661 |
20 | MP0002398_abnormal_bone_marrow | 2.46260785 |
21 | MP0003724_increased_susceptibility_to | 2.36984403 |
22 | MP0002405_respiratory_system_inflammati | 2.35712673 |
23 | MP0005464_abnormal_platelet_physiology | 2.28464195 |
24 | MP0009333_abnormal_splenocyte_physiolog | 2.26915506 |
25 | MP0000716_abnormal_immune_system | 2.26751286 |
26 | MP0002166_altered_tumor_susceptibility | 2.26671050 |
27 | MP0004510_myositis | 2.12683544 |
28 | MP0002396_abnormal_hematopoietic_system | 2.12353996 |
29 | MP0000689_abnormal_spleen_morphology | 2.05084737 |
30 | MP0003300_gastrointestinal_ulcer | 2.02295659 |
31 | MP0009278_abnormal_bone_marrow | 2.01984472 |
32 | MP0002722_abnormal_immune_system | 2.01741023 |
33 | MP0010155_abnormal_intestine_physiology | 1.99592288 |
34 | MP0001853_heart_inflammation | 1.97505654 |
35 | MP0002006_tumorigenesis | 1.92085496 |
36 | MP0002429_abnormal_blood_cell | 1.90823606 |
37 | MP0001845_abnormal_inflammatory_respons | 1.88126636 |
38 | MP0004947_skin_inflammation | 1.85966599 |
39 | MP0005397_hematopoietic_system_phenotyp | 1.79632900 |
40 | MP0001545_abnormal_hematopoietic_system | 1.79632900 |
41 | MP0004808_abnormal_hematopoietic_stem | 1.79272908 |
42 | MP0000703_abnormal_thymus_morphology | 1.74930580 |
43 | MP0001873_stomach_inflammation | 1.74716086 |
44 | MP0001533_abnormal_skeleton_physiology | 1.70606695 |
45 | MP0002933_joint_inflammation | 1.59454438 |
46 | MP0000465_gastrointestinal_hemorrhage | 1.55008849 |
47 | MP0000858_altered_metastatic_potential | 1.53863024 |
48 | MP0005058_abnormal_lysosome_morphology | 1.53609798 |
49 | MP0008260_abnormal_autophagy | 1.49907866 |
50 | MP0005310_abnormal_salivary_gland | 1.48302223 |
51 | MP0003866_abnormal_defecation | 1.43200020 |
52 | MP0008469_abnormal_protein_level | 1.43070286 |
53 | MP0003448_altered_tumor_morphology | 1.41574934 |
54 | MP0005174_abnormal_tail_pigmentation | 1.33532388 |
55 | MP0000490_abnormal_crypts_of | 1.32750476 |
56 | MP0005451_abnormal_body_composition | 1.28516201 |
57 | MP0000343_altered_response_to | 1.27864355 |
58 | MP0003172_abnormal_lysosome_physiology | 1.26055688 |
59 | MP0003191_abnormal_cellular_cholesterol | 1.22455993 |
60 | MP0001851_eye_inflammation | 1.17508580 |
61 | MP0009764_decreased_sensitivity_to | 1.17035795 |
62 | MP0008004_abnormal_stomach_pH | 1.05705989 |
63 | MP0004883_abnormal_blood_vessel | 1.05534361 |
64 | MP0002998_abnormal_bone_remodeling | 1.01013424 |
65 | MP0002019_abnormal_tumor_incidence | 0.99672121 |
66 | MP0005075_abnormal_melanosome_morpholog | 0.96675758 |
67 | MP0003183_abnormal_peptide_metabolism | 0.92338750 |
68 | MP0009840_abnormal_foam_cell | 0.91291796 |
69 | MP0002132_abnormal_respiratory_system | 0.90336665 |
70 | MP0003806_abnormal_nucleotide_metabolis | 0.87487338 |
71 | MP0005166_decreased_susceptibility_to | 0.86715642 |
72 | MP0005023_abnormal_wound_healing | 0.84189310 |
73 | MP0003075_altered_response_to | 0.83813010 |
74 | MP0005164_abnormal_response_to | 0.83704042 |
75 | MP0003690_abnormal_glial_cell | 0.82015255 |
76 | MP0010352_gastrointestinal_tract_polyps | 0.81876337 |
77 | MP0010307_abnormal_tumor_latency | 0.81366866 |
78 | MP0009763_increased_sensitivity_to | 0.80457315 |
79 | MP0000604_amyloidosis | 0.76509323 |
80 | MP0003828_pulmonary_edema | 0.73447712 |
81 | MP0005076_abnormal_cell_differentiation | 0.72549365 |
82 | MP0005390_skeleton_phenotype | 0.72536395 |
83 | MP0001986_abnormal_taste_sensitivity | 0.71905471 |
84 | MP0000015_abnormal_ear_pigmentation | 0.68686651 |
85 | MP0001663_abnormal_digestive_system | 0.68280944 |
86 | MP0003566_abnormal_cell_adhesion | 0.67820166 |
87 | MP0002138_abnormal_hepatobiliary_system | 0.66690812 |
88 | MP0000249_abnormal_blood_vessel | 0.64802455 |
89 | MP0008874_decreased_physiological_sensi | 0.64153170 |
90 | MP0003795_abnormal_bone_structure | 0.63585177 |
91 | MP0003693_abnormal_embryo_hatching | 0.61780972 |
92 | MP0002095_abnormal_skin_pigmentation | 0.59872180 |
93 | MP0003656_abnormal_erythrocyte_physiolo | 0.58896516 |
94 | MP0003279_aneurysm | 0.58723053 |
95 | MP0003077_abnormal_cell_cycle | 0.58072287 |
96 | MP0000313_abnormal_cell_death | 0.57185408 |
97 | MP0002136_abnormal_kidney_physiology | 0.57119005 |
98 | MP0003453_abnormal_keratinocyte_physiol | 0.56593564 |
99 | MP0004381_abnormal_hair_follicle | 0.55481514 |
100 | MP0009765_abnormal_xenobiotic_induced | 0.53947870 |
101 | MP0005167_abnormal_blood-brain_barrier | 0.53315124 |
102 | MP0005381_digestive/alimentary_phenotyp | 0.52321765 |
103 | MP0000371_diluted_coat_color | 0.51757785 |
104 | MP0006054_spinal_hemorrhage | 0.51363891 |
105 | MP0002693_abnormal_pancreas_physiology | 0.50973038 |
106 | MP0002277_abnormal_respiratory_mucosa | 0.50626895 |
107 | MP0008873_increased_physiological_sensi | 0.49096486 |
108 | MP0000477_abnormal_intestine_morphology | 0.48701164 |
109 | MP0000609_abnormal_liver_physiology | 0.48426016 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.48280428 |
111 | MP0008057_abnormal_DNA_replication | 0.46560540 |
112 | MP0003045_fibrosis | 0.45822135 |
113 | MP0008007_abnormal_cellular_replicative | 0.45677761 |
114 | MP0003091_abnormal_cell_migration | 0.44979925 |
115 | MP0004130_abnormal_muscle_cell | 0.44528890 |
116 | MP0005083_abnormal_biliary_tract | 0.44425455 |
117 | MP0002009_preneoplasia | 0.42992807 |
118 | MP0005535_abnormal_body_temperature | 0.40066182 |
119 | MP0000920_abnormal_myelination | 0.38752360 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.03487744 |
2 | Recurrent abscess formation (HP:0002722) | 5.99654195 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.16260442 |
4 | Recurrent fungal infections (HP:0002841) | 4.69487312 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.68247848 |
6 | Myositis (HP:0100614) | 4.36385888 |
7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.21577897 |
8 | IgM deficiency (HP:0002850) | 4.19171345 |
9 | Recurrent viral infections (HP:0004429) | 4.17828706 |
10 | T lymphocytopenia (HP:0005403) | 4.08361690 |
11 | Mediastinal lymphadenopathy (HP:0100721) | 4.05693640 |
12 | Abnormality of T cell number (HP:0011839) | 4.03109172 |
13 | Chronic otitis media (HP:0000389) | 3.96554768 |
14 | Obstructive lung disease (HP:0006536) | 3.95500111 |
15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.95500111 |
16 | Stomatitis (HP:0010280) | 3.95429212 |
17 | Recurrent skin infections (HP:0001581) | 3.90954807 |
18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.86833515 |
19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.86833515 |
20 | Abnormality of macrophages (HP:0004311) | 3.85546836 |
21 | Recurrent bronchitis (HP:0002837) | 3.78225841 |
22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.73103227 |
23 | Meningitis (HP:0001287) | 3.71391712 |
24 | Spontaneous hematomas (HP:0007420) | 3.61646264 |
25 | Abnormality of T cells (HP:0002843) | 3.58856267 |
26 | Autoimmune thrombocytopenia (HP:0001973) | 3.56843413 |
27 | Panhypogammaglobulinemia (HP:0003139) | 3.54088878 |
28 | Cellulitis (HP:0100658) | 3.51836536 |
29 | Nasal polyposis (HP:0100582) | 3.41662633 |
30 | Pustule (HP:0200039) | 3.35314844 |
31 | Abnormality of the nasal mucosa (HP:0000433) | 3.33074674 |
32 | Hypochromic microcytic anemia (HP:0004840) | 3.29465483 |
33 | Severe combined immunodeficiency (HP:0004430) | 3.25411279 |
34 | Orchitis (HP:0100796) | 3.24907172 |
35 | Petechiae (HP:0000967) | 3.24491886 |
36 | Vasculitis (HP:0002633) | 3.24361572 |
37 | Combined immunodeficiency (HP:0005387) | 3.21987880 |
38 | Inflammation of the large intestine (HP:0002037) | 3.16650649 |
39 | Agammaglobulinemia (HP:0004432) | 3.10793529 |
40 | Keratoconjunctivitis (HP:0001096) | 3.10442998 |
41 | Gingivitis (HP:0000230) | 3.10161974 |
42 | Hypochromic anemia (HP:0001931) | 3.09811596 |
43 | Gastrointestinal inflammation (HP:0004386) | 3.09273742 |
44 | Thyroiditis (HP:0100646) | 3.08632081 |
45 | Lymphopenia (HP:0001888) | 3.02602842 |
46 | Leukocytosis (HP:0001974) | 3.01762349 |
47 | Abnormality of T cell physiology (HP:0011840) | 3.00043749 |
48 | Thrombocytosis (HP:0001894) | 2.98632634 |
49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.96276194 |
50 | Optic neuritis (HP:0100653) | 2.95941613 |
51 | Retrobulbar optic neuritis (HP:0100654) | 2.95941613 |
52 | Prolonged bleeding time (HP:0003010) | 2.91777720 |
53 | Vacuolated lymphocytes (HP:0001922) | 2.90806065 |
54 | IgG deficiency (HP:0004315) | 2.84311450 |
55 | Episodic fever (HP:0001954) | 2.83653455 |
56 | Eosinophilia (HP:0001880) | 2.75654245 |
57 | Abnormality of eosinophils (HP:0001879) | 2.73008314 |
58 | Interstitial pulmonary disease (HP:0006530) | 2.69656902 |
59 | Epistaxis (HP:0000421) | 2.65563617 |
60 | Increased cerebral lipofuscin (HP:0011813) | 2.65540655 |
61 | Colitis (HP:0002583) | 2.63803771 |
62 | Urticaria (HP:0001025) | 2.62394447 |
63 | Increased IgE level (HP:0003212) | 2.61837379 |
64 | Hemoptysis (HP:0002105) | 2.60279701 |
65 | Pulmonary embolism (HP:0002204) | 2.59490705 |
66 | Anorexia (HP:0002039) | 2.53735746 |
67 | Granulocytopenia (HP:0001913) | 2.53496701 |
68 | Abnormality of B cell number (HP:0010975) | 2.53484483 |
69 | B lymphocytopenia (HP:0010976) | 2.53484483 |
70 | Encephalitis (HP:0002383) | 2.52454237 |
71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50042757 |
72 | Pulmonary infiltrates (HP:0002113) | 2.46497614 |
73 | Increased IgM level (HP:0003496) | 2.45710002 |
74 | Gingival bleeding (HP:0000225) | 2.44702897 |
75 | Recurrent sinusitis (HP:0011108) | 2.43457230 |
76 | Abnormality of the fingertips (HP:0001211) | 2.42878239 |
77 | Periodontitis (HP:0000704) | 2.42386077 |
78 | Hypergammaglobulinemia (HP:0010702) | 2.39090631 |
79 | Systemic lupus erythematosus (HP:0002725) | 2.37857751 |
80 | Microcytic anemia (HP:0001935) | 2.37083944 |
81 | Osteomyelitis (HP:0002754) | 2.36279363 |
82 | Gastrointestinal stroma tumor (HP:0100723) | 2.35739846 |
83 | Verrucae (HP:0200043) | 2.32515219 |
84 | Papilloma (HP:0012740) | 2.32515219 |
85 | Hepatosplenomegaly (HP:0001433) | 2.29805773 |
86 | Abnormality of the pleura (HP:0002103) | 2.28344516 |
87 | Chest pain (HP:0100749) | 2.27757849 |
88 | Arterial thrombosis (HP:0004420) | 2.27535043 |
89 | Hematochezia (HP:0002573) | 2.27335180 |
90 | Gangrene (HP:0100758) | 2.25379261 |
91 | Amyloidosis (HP:0011034) | 2.24258864 |
92 | Increased serum ferritin (HP:0003281) | 2.22229611 |
93 | Lymphoma (HP:0002665) | 2.21464787 |
94 | Sepsis (HP:0100806) | 2.20005916 |
95 | Chronic diarrhea (HP:0002028) | 2.19996327 |
96 | Skin ulcer (HP:0200042) | 2.18496292 |
97 | Abnormal platelet function (HP:0011869) | 2.17804845 |
98 | Impaired platelet aggregation (HP:0003540) | 2.17804845 |
99 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16804403 |
100 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16804403 |
101 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16804403 |
102 | Chronic sinusitis (HP:0011109) | 2.15393105 |
103 | Recurrent pneumonia (HP:0006532) | 2.15377209 |
104 | Abnormal platelet volume (HP:0011876) | 2.12327351 |
105 | Glomerulopathy (HP:0100820) | 2.12150408 |
106 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10975077 |
107 | Autoimmune hemolytic anemia (HP:0001890) | 2.10133046 |
108 | Purpura (HP:0000979) | 2.09517017 |
109 | Emphysema (HP:0002097) | 2.09004016 |
110 | Abnormality of iron homeostasis (HP:0011031) | 2.08495558 |
111 | Keratoconjunctivitis sicca (HP:0001097) | 2.06930206 |
112 | IgA deficiency (HP:0002720) | 2.06864363 |
113 | Bronchitis (HP:0012387) | 2.05577085 |
114 | Restrictive lung disease (HP:0002091) | 2.04391919 |
115 | Loss of speech (HP:0002371) | 2.03367526 |
116 | Peritonitis (HP:0002586) | 2.03095496 |
117 | Joint swelling (HP:0001386) | 2.02765599 |
118 | Gastrointestinal infarctions (HP:0005244) | 2.02441178 |
119 | Cheilitis (HP:0100825) | 2.01625570 |
120 | Premature loss of primary teeth (HP:0006323) | 2.00785711 |
121 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.99299871 |
122 | Skin rash (HP:0000988) | 1.96265479 |
123 | Abnormality of the peritoneum (HP:0002585) | 1.94874959 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.32053270 |
2 | TXK | 3.58467075 |
3 | BLK | 2.94264783 |
4 | ZAP70 | 2.73877190 |
5 | IRAK4 | 2.70769089 |
6 | TYK2 | 2.64160318 |
7 | PRPF4B | 2.47601557 |
8 | JAK3 | 2.39693162 |
9 | TBK1 | 2.37683483 |
10 | IKBKE | 2.31419142 |
11 | BTK | 2.26569665 |
12 | STK10 | 2.25272930 |
13 | KIT | 2.22171777 |
14 | GRK6 | 2.14099381 |
15 | ERN1 | 2.11144479 |
16 | TEC | 1.92722568 |
17 | MAP3K14 | 1.90714843 |
18 | SYK | 1.84834527 |
19 | ITK | 1.83362810 |
20 | CSK | 1.77984483 |
21 | RIPK4 | 1.72200989 |
22 | MAP3K10 | 1.71849770 |
23 | CSF1R | 1.64737022 |
24 | JAK1 | 1.63841574 |
25 | TGFBR2 | 1.63524941 |
26 | KDR | 1.63262830 |
27 | HCK | 1.58830649 |
28 | MAP3K3 | 1.58774685 |
29 | NME2 | 1.58467802 |
30 | LRRK2 | 1.55020043 |
31 | LCK | 1.54831552 |
32 | FGFR4 | 1.51049812 |
33 | IKBKB | 1.47289967 |
34 | TESK2 | 1.46316973 |
35 | IRAK3 | 1.40366167 |
36 | PKN2 | 1.39766482 |
37 | CLK1 | 1.34187362 |
38 | FES | 1.32023380 |
39 | EPHB1 | 1.31049793 |
40 | EEF2K | 1.29136025 |
41 | RPS6KA4 | 1.25200653 |
42 | MAP2K3 | 1.25083236 |
43 | TRIB3 | 1.24558597 |
44 | PIM1 | 1.23621602 |
45 | LYN | 1.19789584 |
46 | FGFR3 | 1.17778338 |
47 | MAP3K1 | 1.13748463 |
48 | TAOK2 | 1.12287658 |
49 | NLK | 1.06769487 |
50 | MARK3 | 0.98370233 |
51 | BMPR2 | 0.95659828 |
52 | MAP3K13 | 0.93710373 |
53 | TNK2 | 0.93622313 |
54 | JAK2 | 0.93027923 |
55 | SIK2 | 0.90988701 |
56 | KSR2 | 0.89407895 |
57 | TAOK3 | 0.89406775 |
58 | PIM2 | 0.88575183 |
59 | MAP3K12 | 0.82108332 |
60 | MARK2 | 0.81940607 |
61 | FLT3 | 0.81604821 |
62 | YES1 | 0.80524490 |
63 | SMG1 | 0.80345543 |
64 | CDK19 | 0.76566398 |
65 | CHUK | 0.76304060 |
66 | MST4 | 0.73957520 |
67 | MAP3K11 | 0.73656694 |
68 | TGFBR1 | 0.68646299 |
69 | PDPK1 | 0.65703326 |
70 | STK4 | 0.65297099 |
71 | CDK12 | 0.65233700 |
72 | PRKCQ | 0.64776028 |
73 | CDC42BPA | 0.63938433 |
74 | FGR | 0.63003410 |
75 | IRAK2 | 0.60648280 |
76 | CDK4 | 0.60339972 |
77 | PTK6 | 0.58632906 |
78 | SIK3 | 0.58382067 |
79 | PRKCH | 0.58134611 |
80 | PAK4 | 0.58082415 |
81 | TRPM7 | 0.56065513 |
82 | SIK1 | 0.55627553 |
83 | MAPK7 | 0.55605701 |
84 | GRK7 | 0.53567975 |
85 | MATK | 0.50323920 |
86 | NEK9 | 0.49964419 |
87 | CAMKK1 | 0.49089328 |
88 | ALK | 0.48208958 |
89 | PTK2B | 0.47785147 |
90 | CAMKK2 | 0.47359944 |
91 | DYRK1B | 0.46887419 |
92 | RPS6KA6 | 0.46828751 |
93 | TAOK1 | 0.46707507 |
94 | HIPK2 | 0.46377662 |
95 | MAPK4 | 0.45923937 |
96 | MAP3K5 | 0.45175645 |
97 | MAPKAPK2 | 0.43561198 |
98 | PDK1 | 0.41423071 |
99 | NEK2 | 0.41299944 |
100 | MAPK11 | 0.40340701 |
101 | PRKG2 | 0.39785448 |
102 | ABL1 | 0.39378989 |
103 | PRKCD | 0.38694713 |
104 | MAP3K6 | 0.38308690 |
105 | MAP3K8 | 0.36912435 |
106 | CDK6 | 0.36722915 |
107 | FYN | 0.36173621 |
108 | PIK3CG | 0.36065503 |
109 | RPS6KC1 | 0.35065812 |
110 | RPS6KL1 | 0.35065812 |
111 | RET | 0.34875135 |
112 | TESK1 | 0.34222698 |
113 | TTN | 0.34054871 |
114 | EGFR | 0.33475882 |
115 | STK11 | 0.33163719 |
116 | MAP2K6 | 0.32930228 |
117 | MAP2K2 | 0.32604625 |
118 | CDK9 | 0.29412408 |
119 | BMX | 0.27651159 |
120 | IRAK1 | 0.26604183 |
121 | MAP3K7 | 0.25699530 |
122 | MAPK12 | 0.24129881 |
123 | EPHA3 | 0.23700481 |
124 | STK24 | 0.22406008 |
125 | PRKD2 | 0.22362944 |
126 | ILK | 0.22196397 |
127 | CAMK1D | 0.20806459 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.80309126 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.01312611 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45720444 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44241009 |
5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.43528200 |
6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.43431925 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39846247 |
8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.34993691 |
9 | Measles_Homo sapiens_hsa05162 | 2.34779036 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.23279013 |
11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.18942865 |
12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14045020 |
13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.11736085 |
14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03831668 |
15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89983681 |
16 | Allograft rejection_Homo sapiens_hsa05330 | 1.89479564 |
17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.84277344 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81197243 |
19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.80774194 |
20 | Asthma_Homo sapiens_hsa05310 | 1.78217138 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67409792 |
22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63289817 |
23 | Tuberculosis_Homo sapiens_hsa05152 | 1.61929975 |
24 | Shigellosis_Homo sapiens_hsa05131 | 1.61615785 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58335822 |
26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57807730 |
27 | Pertussis_Homo sapiens_hsa05133 | 1.56662432 |
28 | Legionellosis_Homo sapiens_hsa05134 | 1.53593130 |
29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51647636 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51611447 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47947831 |
32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47769929 |
33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45906973 |
34 | Malaria_Homo sapiens_hsa05144 | 1.44938170 |
35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39921080 |
36 | Influenza A_Homo sapiens_hsa05164 | 1.39459709 |
37 | Ribosome_Homo sapiens_hsa03010 | 1.31905018 |
38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31163752 |
39 | Hepatitis B_Homo sapiens_hsa05161 | 1.30676947 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.28923039 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27504789 |
42 | Salmonella infection_Homo sapiens_hsa05132 | 1.27114165 |
43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18368788 |
44 | Platelet activation_Homo sapiens_hsa04611 | 1.12828149 |
45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08602004 |
46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08267482 |
47 | DNA replication_Homo sapiens_hsa03030 | 1.07211119 |
48 | Lysosome_Homo sapiens_hsa04142 | 1.05332425 |
49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01113847 |
50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00123332 |
51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99083631 |
52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98739820 |
53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94294362 |
54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90363970 |
55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89760826 |
56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89657779 |
57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87667943 |
58 | Base excision repair_Homo sapiens_hsa03410 | 0.84297436 |
59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84074503 |
60 | Hepatitis C_Homo sapiens_hsa05160 | 0.81579712 |
61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78069855 |
62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74152738 |
63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.73817659 |
64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70472193 |
65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69520496 |
66 | Mismatch repair_Homo sapiens_hsa03430 | 0.69215168 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67080539 |
68 | Phagosome_Homo sapiens_hsa04145 | 0.64710689 |
69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63125246 |
70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61442564 |
71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59797392 |
72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59186215 |
73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56465046 |
74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55133018 |
75 | Endocytosis_Homo sapiens_hsa04144 | 0.53023325 |
76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51707951 |
77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50003657 |
78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49955095 |
79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49823915 |
80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49022573 |
81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46896528 |
82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46512392 |
83 | Spliceosome_Homo sapiens_hsa03040 | 0.46358607 |
84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45729209 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45408327 |
86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43372510 |
87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43007910 |
88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39353222 |
89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39102518 |
90 | Homologous recombination_Homo sapiens_hsa03440 | 0.38726235 |
91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37598830 |
92 | Amoebiasis_Homo sapiens_hsa05146 | 0.37538858 |
93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36484523 |
94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36081168 |
95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35016839 |
96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33725270 |
97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31363820 |
98 | Insulin resistance_Homo sapiens_hsa04931 | 0.31211825 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30036090 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29540388 |
101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29208271 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26730572 |
103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26358941 |
104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25993595 |
105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25435424 |
106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24498716 |
107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24071002 |
108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23519551 |
109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23464311 |
110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23234312 |
111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22325594 |
112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21957542 |
113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21727842 |
114 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.21184568 |
115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20319305 |
116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20101214 |
117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18646288 |